ArticlePain medicine (Malden, Mass.)2014
How clinicians use prescription drug monitoring programs: a qualitative inquiry.
Article in Pain medicine (Malden, Mass.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Health Care Provider Utilization of Prescription Monitoring Programs: A Systematic Review and Meta-Analysis.Pain medicine (Malden, Mass.) · 2021Pooled it
- Effect of Integrating Access to a Prescription Drug Monitoring Program Within the Electronic Health Record on the Frequency of Queries by Primary Care Clinicians: A Cluster Randomized Clinical Trial.JAMA health forum · 2022Trial
- Past-year Prescription Drug Monitoring Program Opioid Prescriptions and Self-reported Opioid Use in an Emergency Department Population With Opioid Use Disorder.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2018Trial
- Impact of a Mandatory Prescription Drug Monitoring Program on Prescription of Opioid Analgesics by Dentists.PloS one · 2015Trial
- Impacts of a Statewide Prescription Drug Monitoring Program-Healthcare Practitioner Perspectives.Pharmacology research & perspectives · 2026Article
- Healthcare consumers' perceptions and experiences of an Australian prescription drug monitoring program: a cross-sectional survey.Frontiers in digital health · 2026Article
- State-level factors associated with implementation of prescription drug monitoring program integration and mandatory use policies, United States, 2009-2020.Journal of the American Medical Informatics Association : JAMIA · 2024Article
- Exploring Health Informatics in the Battle against Drug Addiction: Digital Solutions for the Rising Concern.Journal of personalized medicine · 2024Review
- Barriers and facilitators related to healthcare practitioner use of real time prescription monitoring tools in Australia.Frontiers in public health · 2023Article
- Automated opioid risk scores: a case for machine learning-induced epistemic injustice in healthcare.Ethics and information technology · 2023Article
- Primary Care Implementation of a Mandatory Prescription Drug Monitoring Program in New York City.The journal of behavioral health services & research · 2022Article
- Optimization of Prescription Drug Monitoring Program to Overcome Opioid Epidemic in West Virginia.Cureus · 2022Review
- Effect of a Prescription Drug Monitoring Program on Emergency Department Opioid Prescribing.The western journal of emergency medicine · 2021Article
- Mandatory use of prescription drug monitoring program and benzodiazepine prescribing among U.S. Medicaid enrollees.Substance abuse · 2021Article
- How Do Clinicians of Different Specialties Perceive and Use Opioid Risk Mitigation Strategies? A Qualitative Study.Substance use & misuse · 2021Article
- The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study.Drug and alcohol dependence · 2020Article
- Evaluation of Prescription Drug Monitoring Program Integration With Hospital Electronic Health Records by US County-Level Opioid Prescribing Rates.JAMA network open · 2020Article
- Factors Influencing Judgments to Consult Prescription Monitoring Programs: A Factorial Survey Experiment.Pain management nursing : official journal of the American Society of Pain Management Nurses · 2020Article
- In Their Own Words: How Opioids Have Impacted the Lives of "Everyday" People Living in Appalachia.Journal of Appalachian health · 2020Article
- Prescription drug monitoring programs and drug overdose deaths involving benzodiazepines and prescription opioids.Drug and alcohol review · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesPrescription drug monitoring programs (PDMPs) are now active in most states to assist clinicians in identifying potential controlled drug misuse, diversion, or excessive prescribing. Little is still known about the ways in which they are incorporated into workflow and clinical decision making, what barriers continue to exist, and how clinicians are sharing PDMP results with their patients.
designQualitative data were collected through online focus groups and telephone interviews.
settingClinicians from pain management, emergency and family medicine, psychiatry/behavioral health, rehabilitation medicine, internal medicine and dentistry participated. PATIENTS: Thirty-five clinicians from nine states participated.
methodsWe conducted two online focus groups and seven telephone interviews. A multidisciplinary team then used a grounded theory approach coupled with an immersion-crystallization strategy for identifying key themes in the resulting transcripts.
resultsSome participants, mainly from pain clinics, reported checking the PDMP with every patient, every time. Others checked only for new patients, for new opioid prescriptions, or for patients for whom they suspected abuse. Participants described varied approaches to sharing PDMP information with patients, including openly discussing potential addiction or safety concerns, avoiding discussion altogether, and approaching discussion confrontationally. Participants described patient anger or denial as a common response and noted the role of patient satisfaction surveys as an influence on prescribing.
conclusionRoutines for accessing PDMP data and how clinicians respond to it vary widely. As PDMP use becomes more widespread, it will be important to understand what approaches are most effective for identifying and addressing unsafe medication use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.